Sort
15,273 grants matching “antimicrobial resistance”
South Africa-Pittsburgh Public Health Genomic Epidemiology Research Training Program (SAPPHGenE)
$242,492Lee H. Harrison · University Of Pittsburgh At Pittsburgh · D43 · FY2023 · TW
Analysis of PASTA kinase function in Enterococcus faecalis
$242,413Christopher J Kristich · Medical College Of Wisconsin · R21 · FY2018 · AI
Neisseria gonorrhoeae central metabolism in the context of neutrophilic inflammation
$242,250Alison K Criss · University Of Virginia · R21 · FY2021 · AI
Staphylococcus Aureus Carriage and the Nasal Microbiome
$242,250Curtis Huttenhower · Harvard School Of Public Health · R21 · FY2015 · AI
Novel translational strategies to combat group B streptococcus infections
$242,250Muthiah Kumaraswami · Methodist Hospital Research Institute · R21 · FY2025 · AI
Research Initiation Award: Antagonistic Bacteriophage and Metal Combination Treatment to Combat the Spread of Antimicrobial Resistance
$242,188Rasheena Edmondson · Shaw University · · FY2021 · EDU
Genetics of Salmonella Resistance to the Inflammatory Response in the Gut
$242,125Helene L Andrews-Polymenis · Texas A&M University Health Science Ctr · R21 · FY2009 · AI
Antimicrobial peptides as models for the evolution of gene duplication
$242,115Robert L Unckless · University Of Kansas Lawrence · R00 · FY2016 · GM
A novel anti-gonorrhea immunotherapeutic
$242,093Keith Wycoff · Planet Biotechnology, Inc. · R41 · FY2017 · AI
Gamma delta IEL control of intestinal infection: roles for CD100 and JAML
$241,875Deborah A Witherden · Scripps Research Institute, The · R21 · FY2020 · AI
Rapid antimicrobial susceptibility determination of bacterial pathogens
$241,845Robert M Dickson · Georgia Institute Of Technology · R01 · FY2014 · AI
The BLAAST Trial: Bangladesh Lung Auscultation AI for Antibiotic Stewardship Randomized Controlled Trial
$241,747Eric Douglass McCollum · Johns Hopkins University · R01 · FY2025 · HD
Role of M3 peptidases in Staphylococcus aureus pathogenesis
$241,744Shaun R Brinsmade · Georgetown University · R21 · FY2023 · AI
House Cleaner Tolerance in S. aureus
$241,718John E Gustafson · New Mexico State University Las Cruces · S06 · FY2007 · GM
Mechanism of Azithromycin Activity in Pseudomonas Infections
$241,690Alan R Hauser · Northwestern University At Chicago · R21 · FY2010 · AI
Functional roles of ncRNA afu-182 in azole response and pathobiology of Aspergillus fumigatus
$241,631Sourabh Dhingra · Clemson University · P20 · FY2023 · GM
Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal Infection
$241,530Lauren Jo Delaney · Thomas Jefferson University · R00 · FY2024 · AR
Implications of mycoviral infection in Talaromyces marneffei: an analysis of human patient samples, RNAi, and hypermutation
$241,500Joseph Heitman · Duke University · R21 · FY2022 · AI
Resistance of Bacillus anthracis to lysozyme
$241,500Jonathan Dworkin · Columbia University Health Sciences · R21 · FY2008 · AI
Neutrophil Activation Phenotypes in Healthy Subjects and Implications for Bacterial Clearance
$241,500Grace Ming Lee · Duke University · R21 · FY2021 · AI
Developing novel pyrazolidinone antibiotics targeting PBP3 to overcome resistance mechanisms
$241,500Focco Van Den Akker · Case Western Reserve University · R21 · FY2023 · AI
Targeting Escherichia coli PBP1b using fragment-based approaches
$241,500Focco Van Den Akker · Case Western Reserve University · R21 · FY2022 · AI
Accelerating microbiota recovery to protect against Clostridioides difficile
$241,500Jee-Yon Lee · University Of California At Davis · R21 · FY2025 · AI
Regulation of group 1 ILCs by a novel lncRNA
$241,500Jorge Henao-Mejia · University Of Pennsylvania · R21 · FY2017 · AI
GAIT complex formation and Mycobacterium tuberculosis
$241,500Liem Duy Nguyen · Case Western Reserve University · R21 · FY2021 · AI